RT Journal Article
SR Electronic
T1 Novel scotoma detection method using time required for fixation to the random targets
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.03.21258101
DO 10.1101/2021.06.03.21258101
A1 Nobuyuki Takahashi
A1 Shozo Saeki
A1 Minoru Kawahara
A1 Hirohisa Aman
A1 Eri Nakano
A1 Yuki Mori
A1 Masahiro Miyake
A1 Hiroshi Tamura
A1 Akitaka Tsujikawa
YR 2021
UL http://medrxiv.org/content/early/2021/09/28/2021.06.03.21258101.abstract
AB We developed a novel scotoma detection system using time required for fixation to the random targets, or the” eye-guided scotoma detection method “. In order to verify the” eye-guided scotoma detection method “, we measured 78 eyes of 40 subjects, and examined the measurement results in comparison with the results of measurement by Humphrey perimetry. The results were as follows: (1) Mariotte scotomas were detected in 100% of the eyes tested; (2) The false-negative rate (the percentage of cases where a scotoma was evaluated as a non-scotoma) was less than 10%; (3) The positive point distribution in the low-sensitivity eyes was well matched. These findings suggested that the novel scotoma detection method in the current study will pave the way for the realization of mass screening to detect pathological scotoma earlier.Author summary Conventional perimeters, such as the Goldmann perimeter and Humphrey perimeter, require experienced examiners and space occupying. With either perimeter, subjects’ eye movements need to be strictly fixed to the fixation target of the device. Other perimeters can monitor fixation and automatically measure the visual field. With the eye-guided scotoma detection method proposed in the current study, subjects feel less burdened since they do not have to fixate on the fixation target of the device and can move their eyes freely. Subjects simply respond to visual targets on the display; then, scotomas can be automatically detected. The novel method yields highly accurate scotoma detection through an algorithm that separates scotomas from non-scotomas.Competing Interest StatementThis research unrestricted research grants from FINDEX Inc. This research relates the patent application which is "VISUAL FIELD MEASURING METHOD, VISUAL FIELD MEASURING APPARATUS, AND OPTOTYPE," US 10,687,700 B2. Shozo Saeki has employed by FINDEX Inc. Dr. Kawahara reports grants from JSPS KAKENHI JP18K11528 and grants from Findex. Dr. Miyake reports personal fees from Santen Pharm., personal fees from Nevaker, personal fees from Novartis Pharm., personal fees from Japan Alcon, personal fees from HOYA, personal fees from Kowa Pharm., personal fees from Senju Pharm., personal fees from Ellex, personal fees from Johnson & Johnson, personal fees from AMO Japan, outside the submitted work;. Dr. Tamura reports grants from Ministry of Health, Labor, and Welfare, personal fees from Novartis, personal fees from Santen Pharmaceutical, personal fees from Bayer Yakuhin, personal fees from Suntory, outside the submitted work. Dr. Tsujikawa reports grants and personal fees from Canon, grants from Findex, grants and personal fees from Santen Pharmaceutical, grants from Kowa Pharmaceutical, grants from Pfizer, grants and personal fees from AMO Japan, grants and personal fees from Senju Pharmaceutical, grants and personal fees from Wakamoto Pharmaceutical, grants and personal fees from Alcon Japan, grants and personal fees from Alcon Pharma, grants and personal fees from Otsuka Pharmaceutical, grants from Tomey Corporation, grants from Taiho Pharma, personal fees from Hoya, personal fees from Bayer Yakuhin, personal fees from Novartis Pharma, personal fees from Chugai Pharmaceutical, personal fees from Astellas, personal fees from Eisai, personal fees from Daiichi-Sankyo, personal fees from Janssen Pharmaceutical, personal fees from Kyoto Drug Discovery & Development, personal fees from Allergan Japan, personal fees from Sanwa Kagaku Kenkyusho, personal fees from Nitten Pharmaceutical, personal fees from Otsuka Pharmaceutical, outside the submitted work.Clinical TrialTrial ID is UMIN000038206Funding StatementMinoru Kawahara.: JSPS KAKENHI Grant Number JP18K11528, https://www.jsps.go.jp. Minoru Kawahara, Hiroshi Tamura, and Akitaka Tsujikawa received funding from FINDEX Inc. (https://findex.co.jp/en/index.html)FINDEX Inc. FINDEX Inc. had the role which data collection and the process of proofreading the manuscript in the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Review Board at Findex Inc.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data gathered during and analyzed in the current study are not publicly available to the restrictions of the commercially but are available from the corresponding author on reasonable request. https://www.kaggle.com/shozosaeki/visual-field-testing-experiment